Grace John
University of Houston
5 Papers
1 Citations
Grace John is an academic researcher from University of Houston. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Identifying adherence barriers to oral endocrine therapy among breast cancer survivors.
TL;DR: The three categories of adherence barriers should be evaluated and considered when designing future interventions to enhance OET adherence for a tailored approach.
77
A study on seroconversion following first & second doses of ChAdOx1 nCoV-19 vaccine in Central Kerala
Sangeeth Varghese,GeorgeChandy Mateethra,Geomcy George,V Chandran,Grace John,L. Varghese,Nithin K Mammen,V. K. Vinayak +7 more
TL;DR: ChAdOx1 nCov-19 vaccine after two doses elicited an excellent immune response, however, greater immunogenicity after the first dose was seen among those with previous COVID-19 infection, even surpassing the titre achieved by the second dose of vaccine in SARS CoV-2 naïve recipients.
5
A study on seroconversion following first & second doses of ChAdOx1 nCoV-19 vaccine in central Kerala
Sangeeth Varghese,GeorgeChandy Mateethra,Geomcy George,V Chandran,Grace John,L. Varghese,Nithin K Mammen,V. K. Vinayak +7 more
TL;DR: In this article , a cross-sectional COVID-19 vaccine-induced antibody study was conducted among healthcare workers, where the mean and median antibody titre following each dose of vaccine and its association with age, gender, co-morbidities and factors such as exercise, stress and sleep deprivation were also explored.
1
COVID-19 Vaccines Portray the Bright Side of Human Creativity, But It Means Nothing until They Prove Their Worth: A Study on Seroconversion after the first Dose of Covishield Vaccine in Central Kerala
Sangeeth Varghese,Arun Sachu,L. Jacob,Geomcy George,George Chandy,Abel K. Samuel Johnson,Grace John +6 more
TL;DR: Seroconversion rate of more than 90% offers a promising hope toward successful pandemic control in the current scenario, the inability to attain the targeted coverage due to an upsurge in vaccine hesitancy, compounded with only lower proportion of seroconversion in elderly, faster rollout of the vaccines without any age limit, will help achieve the herd threshold more rapidly.
1
Active surveillance of adverse events following the first dose of COVID-19 vaccination – Oxford–AstraZeneca (Covishield) vaccine
Sangeeth Varghese,Grace John,Geomcy George,L. Jacob,Mammen Paul,Arun Sachu,Abel K. Samuel Johnson,George Chandy +7 more
TL;DR: This study shows that COVID vaccines are safe in the Indian population and the side effects are similar to any other vaccine and may help to dispel any fear and misinformation regarding COVID-19 vaccination and thus maximize the benefit of the nationwide immunization program.